Goldman Sachs Debunks AI Bubble Fears: Why It’s Not The Next Dot-Com Disaster

Goldman Sachs’ equity strategists team led by Peter Oppenheimer recently unveiled a thought-provoking analysis titled “Why AI is…

Goldman Sachs’ equity strategists team led by Peter Oppenheimer recently unveiled a thought-provoking analysis titled “Why AI is not a bubble,” stating that the new technology is still in its infancy and has the potential to continue outperforming other markets in the future.

This came amid the soaring performance of AI-related stocks in 2023 with questions emerging among investors and analysts about a potential bubble in the AI sector.

AI vs. Dot-Com Bubble: What’s The Crucial Difference?

Drawing parallels with the dot-com bubble of the late ’90s, Goldman Sachs acknowledges that in both cases, investors recognized the potential for groundbreaking innovations.

The tech boom of the ’90s saw the fast rise of major tech companies, but the bubble burst and wiped out newcomers who hadn’t yet turned profitable.

In contrast, the current AI ecosystem boasts a crucial difference: early winners show robust financial positions and impressive returns on investment.

Also Read: EXCLUSIVE: Cathie Wood Breaks Down $2,000 Tesla Price Target With Benzinga

Meet The AI “Early Winners“

Goldman Sachs has identified 11 U.S. companies poised to reap the rewards of the AI revolution in its early stages. The list has been categorized into three distinct subgroups:

  • Enablers: NVIDIA Corp. (NASDAQ:NVDA), Marvell Technology Group Ltd. (NASDAQ:MRVL), and CrowdStrike Holdings Inc. (NASDAQ:CRWD)
  • Hyperscalers: Microsoft Corporation (NASDAQ:MSFT), Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL), and Amazon.com, Inc. (NASDAQ:AMZN)
  • Empowered Users: Meta Platforms Inc. (NASDAQ:META), Salesforce.com Inc. (NYSE:CRM), Adobe Inc. (NASDAQ:ADBE), ServiceNow Inc. (NYSE:NOW) and Intuit Inc. (NASDAQ:INTU).

According to Goldman Sachs, AI’s pioneers are anticipated to continue outperforming as the technology scales, having already risen significantly this year, increasing 65% as a basket.

Where To Find Value In AI Technological Revolution

Goldman Sachs identified elevated opportunities in the so-called “reformers” that are reshaping industries using AI. Companies with exceptional execution skills, known as “adaptors,” may also provide attractive investment opportunities.

As AI adoption becomes widespread, consumers are likely to benefit, and companies that capitalize on this shift may outperform market expectations.

Goldman Sachs has also unveiled a long-term portfolio comprising 50 stocks, strategically positioned to harness the growth potential of AI evolution. Find out which 50 stocks Goldman Sachs considers to be the best in the AI space, by clicking here.

Now Read: Microsoft-Backed Startup D-Matrix To Compete With Nvidia In Bid For AI Dominance

Photo: Shutterstock

Total
0
Shares
Related Posts
Read More

Cocaine, Meth Decriminalization In Maine, NY Weed Market Expands, Cannabis Reg Updates In AR And FL

On Friday, a New York regulator green-lighted two more marijuana multistate operators to transition to the recreational market from the medical. Fiorello Pharmaceuticals Inc. - owned by Green Thumb Industries Inc and running dispensaries in Manhattan, Long Beach, Rochester and Half Moon - and Citiva Medical LLC - owned by iAnthus Capital Holdings Inc. and operating medical dispensaries doing business as "Be" in Brooklyn, Wappingers Falls, Staten Island and Ithaca– were approved by the members of New York Cannabis Control Board (CCB) in the anonymous vote. In the meantime, on Jan. 12, Arkansans for Patient Access, a ballot committee, submitted a proposed ballot initiative to Arkansas Attorney General Tim Griffin to amend Amendment 98, the state's medical marijuana amendment. In Maine, a new push seeks to decriminalize the possession of small quantities of illegal drugs and allocate resources towards treating substance use disorder instead of enforcing punitive measures. More Floridians are opting to register as medical marijuana patients, at least according to the 2024 Physician Certification Pattern Review annual report that highlighted figures from fiscal year 2023.

CSE:GTII